Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 1 | $39,032,821 |
Sells | 41 | $15,012,187 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
22 Feb 2024 16:34 | VYGR | Voyager Therapeutics Inc | SANDROCK ALFRED | President and CEO | 21 Feb 2024 | Sale | 13,033 | 7.46 | 97,226 | D |
22 Feb 2024 16:36 | VYGR | Voyager Therapeutics Inc | SWARTZ ROBIN | Chief Operating Officer | 21 Feb 2024 | Sale | 3,966 | 7.45 | 29,547 | D |
22 Feb 2024 16:30 | VYGR | Voyager Therapeutics Inc | CARTER TODD ALFRED | Chief Scientific Officer | 21 Feb 2024 | Sale | 3,365 | 7.47 | 25,137 | D |
22 Feb 2024 16:30 | VYGR | Voyager Therapeutics Inc | CARTER TODD ALFRED | Chief Scientific Officer | 20 Feb 2024 | Sale | 602 | 7.68 | 4,623 | D |
22 Feb 2024 16:32 | VYGR | Voyager Therapeutics Inc | PFREUNDSCHUH PETER P. | Chief Financial Officer | 21 Feb 2024 | Sale | 3,764 | 7.46 | 28,079 | D |
19 Jan 2024 16:34 | VYGR | Voyager Therapeutics Inc | SWARTZ ROBIN | Chief Operating Officer | 17 Jan 2024 | Sale | 2,543 | 7.15 | 18,182 | D |
19 Jan 2024 16:32 | VYGR | Voyager Therapeutics Inc | CARTER TODD ALFRED | Chief Scientific Officer | 17 Jan 2024 | Sale | 1,266 | 7.18 | 9,090 | D |
05 Oct 2023 16:41 | VYGR | Voyager Therapeutics Inc | PFREUNDSCHUH PETER P. | Chief Financial Officer | 03 Oct 2023 | Sale | 13,567 | 6.99 | 94,833 | D |
18 Sep 2023 16:44 | VYGR | Voyager Therapeutics Inc | CARTER TODD ALFRED | Chief Scientific Officer | 15 Sep 2023 | Sale | 10,500 | 8.16 | 85,680 | D |
03 Apr 2024 16:10 | VYGR | Voyager Therapeutics Inc | SANDROCK ALFRED | President and CEO | 02 Apr 2024 | Sale | 12,115 | 9.86 | 119,454 | D |
03 Apr 2024 16:13 | VYGR | Voyager Therapeutics Inc | SWARTZ ROBIN | Chief Operating Officer | 02 Apr 2024 | Sale | 1,357 | 9.88 | 13,407 | D |
10 Jul 2023 16:42 | VYGR | Voyager Therapeutics Inc | CARTER TODD ALFRED | Chief Scientific Officer | 06 Jul 2023 | Sale | 5,500 | 10.8 | 59,400 | D |
05 Apr 2023 17:04 | VYGR | Voyager Therapeutics Inc | SANDROCK ALFRED | President and CEO | 03 Apr 2023 | Sale | 7,437 | 7.83 | 58,232 | D |
05 Apr 2023 17:02 | VYGR | Voyager Therapeutics Inc | SWARTZ ROBIN | Chief Operating Officer | 03 Apr 2023 | Sale | 1,259 | 7.83 | 9,858 | D |
22 Mar 2023 16:49 | VYGR | Voyager Therapeutics Inc | CARTER TODD ALFRED | Chief Scientific Officer | 20 Mar 2023 | Sale | 2,193 | 7.76 | 17,018 | D |
22 Mar 2023 16:47 | VYGR | Voyager Therapeutics Inc | HESSLEIN ROBERT W. | Senior VP & General Counsel | 20 Mar 2023 | Sale | 4,410 | 7.76 | 34,222 | D |
22 Mar 2023 16:48 | VYGR | Voyager Therapeutics Inc | SWARTZ ROBIN | Chief Operating Officer | 20 Mar 2023 | Sale | 3,654 | 7.76 | 28,355 | D |
17 Mar 2023 16:37 | VYGR | Voyager Therapeutics Inc | SWARTZ ROBIN | Chief Operating Officer | 15 Mar 2023 | Sale | 15,373 | 8.2 | 126,059 | D |
24 Feb 2023 06:15 | VYGR | Voyager Therapeutics Inc | NEUROCRINE BIOSCIENCES INC | 10% | 23 Feb 2023 | Purchase | 4,395,588 | 8.88 | 39,032,821 | D |
22 Feb 2023 20:57 | VYGR | Voyager Therapeutics Inc | CARTER TODD ALFRED | Chief Scientific Officer | 17 Feb 2023 | Sale | 738 | 7.45 | 5,498 | D |
22 Feb 2023 20:58 | VYGR | Voyager Therapeutics Inc | HESSLEIN ROBERT W. | Senior VP & General Counsel | 17 Feb 2023 | Sale | 3,297 | 7.45 | 24,563 | D |
15 Feb 2023 16:52 | VYGR | Voyager Therapeutics Inc | HESSLEIN ROBERT W. | Senior VP & General Counsel | 13 Feb 2023 | Sale | 2,868 | 7.67 | 21,998 | D |
15 Feb 2023 16:53 | VYGR | Voyager Therapeutics Inc | CARTER TODD ALFRED | Chief Scientific Officer | 13 Feb 2023 | Sale | 797 | 7.67 | 6,113 | D |
01 Feb 2023 19:26 | VYGR | Voyager Therapeutics Inc | THIRD ROCK VENTURES III, L.P. | 10% | 01 Feb 2023 | Sale | 128,642 | 9.32 | 1,198,943 | D |
01 Feb 2023 19:26 | VYGR | Voyager Therapeutics Inc | THIRD ROCK VENTURES III, L.P. | 10% | 31 Jan 2023 | Sale | 185,000 | 9.25 | 1,711,250 | D |
01 Feb 2023 19:26 | VYGR | Voyager Therapeutics Inc | THIRD ROCK VENTURES III, L.P. | 10% | 30 Jan 2023 | Sale | 75,000 | 9.03 | 677,250 | D |
31 Jan 2023 16:30 | VYGR | Voyager Therapeutics Inc | THIRD ROCK VENTURES III, L.P. | 10% | 27 Jan 2023 | Sale | 50,000 | 9.02 | 451,000 | D |
26 Jan 2023 17:23 | VYGR | Voyager Therapeutics Inc | THIRD ROCK VENTURES III, L.P. | 10% | 25 Jan 2023 | Sale | 50,000 | 9.22 | 461,000 | D |
26 Jan 2023 17:23 | VYGR | Voyager Therapeutics Inc | THIRD ROCK VENTURES III, L.P. | 10% | 24 Jan 2023 | Sale | 100,000 | 9.27 | 927,000 | D |
24 Jan 2023 18:20 | VYGR | Voyager Therapeutics Inc | THIRD ROCK VENTURES III, L.P. | 10% | 23 Jan 2023 | Sale | 55,000 | 9.06 | 498,300 | D |
24 Jan 2023 18:20 | VYGR | Voyager Therapeutics Inc | THIRD ROCK VENTURES III, L.P. | 10% | 20 Jan 2023 | Sale | 100,000 | 9.15 | 915,000 | D |
19 Jan 2023 16:55 | VYGR | Voyager Therapeutics Inc | CARTER TODD ALFRED | Chief Scientific Officer | 17 Jan 2023 | Sale | 400 | 10.34 | 4,136 | D |
19 Jan 2023 16:55 | VYGR | Voyager Therapeutics Inc | CARTER TODD ALFRED | Chief Scientific Officer | 17 Jan 2023 | Sale | 706 | 9.57 | 6,756 | D |
19 Jan 2023 16:57 | VYGR | Voyager Therapeutics Inc | HESSLEIN ROBERT W. | Senior VP & General Counsel | 17 Jan 2023 | Sale | 792 | 10.34 | 8,189 | D |
19 Jan 2023 16:57 | VYGR | Voyager Therapeutics Inc | HESSLEIN ROBERT W. | Senior VP & General Counsel | 17 Jan 2023 | Sale | 1,396 | 9.57 | 13,360 | D |
19 Jan 2023 16:53 | VYGR | Voyager Therapeutics Inc | SWARTZ ROBIN | Chief Operating Officer | 17 Jan 2023 | Sale | 792 | 10.34 | 8,189 | D |
19 Jan 2023 16:53 | VYGR | Voyager Therapeutics Inc | SWARTZ ROBIN | Chief Operating Officer | 17 Jan 2023 | Sale | 1,396 | 9.57 | 13,360 | D |
11 Jan 2023 18:26 | VYGR | Voyager Therapeutics Inc | ECOR1 CAPITAL, LLC | 10% | 11 Jan 2023 | Sale | 110,000 | 8.4965 | 934,615 | I |
11 Jan 2023 18:26 | VYGR | Voyager Therapeutics Inc | ECOR1 CAPITAL, LLC | 10% | 10 Jan 2023 | Sale | 336,400 | 8.0542 | 2,709,433 | I |
11 Jan 2023 18:26 | VYGR | Voyager Therapeutics Inc | ECOR1 CAPITAL, LLC | 10% | 09 Jan 2023 | Sale | 456,000 | 7.6717 | 3,498,295 | I |
10 Jan 2023 16:07 | VYGR | Voyager Therapeutics Inc | CARTER TODD ALFRED | Chief Scientific Officer | 06 Jan 2023 | Sale | 388 | 6.41 | 2,487 | D |
05 Jul 2023 16:32 | VYGR | Voyager Therapeutics Inc | CARTER TODD ALFRED | Chief Scientific Officer | 30 Jun 2023 | Sale | 5,000 | 11.41 | 57,050 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)